QBTS · D-Wave Quantum Inc.

Current Thesis

D-Wave Quantum’s recovery thesis now combines a definitive federal funding agreement with enterprise commercialisation; recognition of the previously booked $20 million system sale in Q3 would establish revenue conversion, while a weekly close below $16.18 would invalidate the recovery case.

The September 8 announcement changes the September 3 assessment: the CHIPS and Science Act agreement has advanced beyond the May 21 letter of intent. Commerce confirmed a final award of up to $100 million for quantum computing research and development. That resolves the agreement-signing uncertainty, but does not establish receipt of the full award or customer revenue. Commerce announcement, 2026-09-08.

The life-cycle assessment is an inference: the narrative is maturing — the federal funding story announced on 2026-05-21 reached a definitive agreement on 2026-09-08, while the 2026-09-11 reference close remained $16.80, with the shares down 28.1% over three months. The funding development makes the earlier description of a dead narrative too broad; the available price observations remain insufficient to establish renewed participation.

Bullish and bearish views on D-Wave Quantum Inc.

The model's bull view on D-Wave Quantum Inc. (QBTS), in brief: Federal agreement becomes definitive. The Form 8-K filed on 2026-09-08 says the agreement was signed on 2026-09-04 and an initial $53,552,620 tranche would become available shortly afterward. Actual receipt remains unconfirmed in that filing. D-Wave Form 8-K. Contracted revenue… The bear view: Reported revenue still disappoints. Benzinga’s 2026-08-06 earnings report recorded Q2 revenue of $3.076 million against a $4.025 million estimate, with operating loss of $54.7 million. Contract announcements have yet to resolve the gap between bookings and reported sales shown… Both cases follow in full.

Bull Case

• Federal agreement becomes definitive. The Form 8-K filed on 2026-09-08 says the agreement was signed on 2026-09-04 and an initial $53,552,620 tranche would become available shortly afterward. Actual receipt remains unconfirmed in that filing. D-Wave Form 8-K.
• Contracted revenue exceeds current sales. D-Wave’s Q2 release dated 2026-08-06 reported remaining performance obligations (RPO), or contracted revenue awaiting recognition, of $40.7 million at 2026-06-30. Management expected approximately 57% to be recognised within twelve months; that expectation would fail if subsequent disclosures show recognition slipping beyond that window.
• System conversion offers measurable upside. The 2026-08-06 results context identified a $20 million system sale booked during the first half but not yet recognised. Q3 recognition defines the operating success condition for this recovery thesis; deferral beyond Q3 would defeat that near-term case.

Bear Case

• Reported revenue still disappoints. Benzinga’s 2026-08-06 earnings report recorded Q2 revenue of $3.076 million against a $4.025 million estimate, with operating loss of $54.7 million. Contract announcements have yet to resolve the gap between bookings and reported sales shown by that print.
• Funding includes equity dilution. The 2026-09-08 filing describes anticipated common-stock issuance to Commerce and warns that funding depends on conditions and appropriations. It also permits termination for convenience with 60 days’ notice; an award announcement does not establish unrestricted cash availability. D-Wave Form 8-K.
• Finance leadership remains a checkpoint. The company’s 2026-08-25 announcement named Greg Golkov acting chief financial officer following John Markovich’s resignation effective 2026-09-02. The announcement stated there was no disagreement over accounting, financial statements or internal controls; a delayed Q3 filing or subsequent accounting correction would provide contrary evidence.

Setup & Price Structure

The adjusted daily-bar reference for 2026-09-11 records a $16.80 close, 62.5% below the $44.78 trailing-year high, and a 14-day relative strength index (RSI) of 30.6. These are measured observations. They do not establish a completed base or predict a rebound.

The 2026-07-29 market low of $16.18 remains the published structural reference. The September 11 close is above it, but the supplied observations cannot establish an uninterrupted sequence of higher lows. Current moving-average values are missing, so the August readings cannot describe today’s trend.

Stock Analysis’s 2026-08-21 snapshot reported 65.91 million shares short, representing 17.70% of shares outstanding. That dated observation supports attention to squeeze mechanics, but the September 10 release value is missing; current covering cannot be inferred. Zacks featured D-Wave in coverage dated September 8 and September 11, an observable cluster whose sample is too small to establish retail crowding. Zacks coverage, 2026-09-11.

Catalyst Calendar (next 30 days)

• 2026-09-24 — Short-interest publication. FINRA’s calendar specifies publication for the 2026-09-15 settlement date. The release measures outstanding short interest after the funding announcement; a change alone cannot identify what drove the share price. FINRA reporting calendar.
• 2026-09-24 — Oil-and-gas webinar. D-Wave lists a quantum-optimisation webinar on its events calendar. Commercial evidence would require a disclosed deployment or contract; the scheduled presentation itself establishes neither. D-Wave events calendar.
• 2026-10-09 — Short-interest publication. FINRA schedules publication for the 2026-09-30 settlement date, providing another dated observation after the award announcement. FINRA reporting calendar.
• ~2026-11-05, estimated — Q3 results. This remains an unconfirmed estimate outside the next thirty days. The operating thesis turns on whether the $20 million system sale identified in the 2026-08-06 results is recognised and whether the named enterprise agreements receive disclosed financial values.

What Would Change Our Mind

Loss of the July support would break the recovery structure: a weekly close below $16.18 would breach the 2026-07-29 market low. Separately, management deferring the previously booked $20 million system sale beyond Q3 would invalidate the proposed near-term revenue conversion.

The operating case would be established by Q3 recognition of that sale before the price condition fires. Until then, the 2026-08-06 revenue miss and the 2026-09-11 close near July support justify low conviction despite the definitive funding agreement.

Correlation Notes

This is a single-name thesis; it does not require a quantum-sector rally. Commerce’s 2026-09-08 announcements finalised awards for both D-Wave and Rigetti, establishing shared policy exposure without establishing a return correlation. NIST CHIPS announcements.

TipRanks attributed the 2026-09-01 decline across QBTS, IONQ, RGTI and QUBT to Treasury yields and inflation concerns. That is the source’s interpretation of one session. The sample is too small to establish a stable relationship with yields or peers.